Maculaser Ltd
Maculaser develops novel medical technology for treatment of common retinal diseases, including dry Age-related Macular Degeneration. The core of our innovation is the precise temperature control of the macula during non-damaging laser treatments; a potential game changer in the practise of how major retinal diseases, with over USD 400B direct health care costs, are being treated in the future. Our innovations allow clinicians to perform previously infeasible laser therapy and potentially help millions of people to retain their vision.
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
5
1 to 10 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 5 verified contacts at Maculaser Ltd
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
- OK
Ossi Kaikkonen
Head of Product · Sales & Business Development
EmailPhone - JN
Jaakko Nieminen
Chief Technology Officer · Other
EmailPhone - JT
Jani Tirronen
CEO & Co-founder · Other
EmailPhone - TT
Teemu Turunen
Chief Scientific Officer · Science
EmailPhone
Showing 4 of 5 verified contacts
Top roles at Maculaser Ltd
4 distinct titles indexed · top 4 shown.
- 1ceo & co-founder
- 1chief scientific officer
- 1chief technology officer
- 1head of product
Sign up to unlock all 5 contacts at Maculaser Ltd
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Maculaser Ltd
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.